Genomic Signatures of Influenza A Pandemic (H1N1) 2009 Virus by Chen, Guang-Wu & Shih, Shin-Ru
Adaptive mutations that have contributed to the emer-
gence of inﬂ  uenza A pandemic (H1N1) 2009 virus, which 
can replicate and transmit among humans, remain unknown. 
We conducted a large-scale scanning of inﬂ  uenza protein 
sequences and identiﬁ  ed amino acid–conserving positions 
that are speciﬁ  c to host species, called signatures. Of 47 sig-
natures that separate avian viruses from human viruses by 
their nonglycoproteins, 8 were human-like in the pandemic 
(H1N1) 2009 virus. Close examination of their amino acid 
residues in the recent ancestral swine viruses of pandemic 
(H1N1) 2009 virus showed that 7 had already transitioned 
to human-like residues and only PA 356 retained an avian-
like K; in pandemic (H1N1) 2009 virus, this residue changed 
into a human-like R. Signatures that separate swine viruses 
from human viruses were also present. Continuous monitor-
ing of these signatures in nonhuman species will help with 
inﬂ  uenza surveillance and with evaluation of the likelihood 
of further adaptation to humans.
A 
recent outbreak of pandemic (H1N1) 2009, previously 
known as the swine-origin inﬂ  uenza A, has infected 
>296,000 persons worldwide; 3,486 deaths have been re-
ported (1). An increased number of infected humans can 
potentially alter virulence in the human population. The 
genomic sequences of many of the new strains of pandemic 
(H1N1) 2009 virus have revealed important information 
for promoting medical diagnosis, drug-resistance monitor-
ing, clinical and basic research, and vaccine development. 
Nevertheless, analyzing adaptive mutation of the new pan-
demic (H1N1) 2009 virus is a priority so that researchers 
can evaluate the likelihood that viruses from other nonhu-
man species will further adapt to humans. 
Pandemic (H1N1) 2009 virus consists of multiple re-
assorted virus genes from different origins. Of its 8 seg-
mented genomic RNAs, 2 polymerase genes, PB2 and PA, 
were from the avian virus of North American lineage and 
were introduced into swine populations around 1998. The 
other polymerase gene, PB1, also evolved recently from a 
human seasonal inﬂ  uenza (H3N2) virus around the same 
year. This particular H3N2 PB1 gene is known to have 
originated from an avian virus that entered humans in 
1968. However, hemagglutinin (HA), nucleoprotein (NP), 
and nonstructural (NS) protein genes of pandemic (H1N1) 
2009 virus descended directly from the classic swine in-
ﬂ  uenza A virus of North American lineage, which can be 
traced back to the 1918 virus. Originating from the Eur-
asian swine virus, the remaining 2 genes, neuraminidase 
(NA) and matrix (M), were introduced from birds around 
1979 (2,3). Limited information is available as to how this 
unique combination of gene segments evolved from 1998 
until it was identiﬁ  ed in April 2009 or on the molecular 
transitions or evolutionary path of this virus before it was 
transmitted among humans.
Our previous study developed an entropy-based com-
putational scheme to identify host-speciﬁ  c genomic signa-
tures of human and avian inﬂ  uenza viruses (4). This method 
is based on an entropy threshold computed from the amino 
acid composition at the well known PB2-627 position of 
avian inﬂ  uenza viruses (entropy value of 0.4 was based 
on 95 avian inﬂ  uenza genomes, as of early 2006), which 
contains mostly glutamic acid in the native avian hosts of 
the viruses. This threshold was then used to identify the 52 
species-associated positions at which each of the 2 viruses 
settles as a distinct amino acid residue that is characteristic 
of the host. Although the origin of the gene segments in 
pandemic (H1N1) 2009 virus has been determined (2,3), 
the mechanism of transformation of the host-speciﬁ  c ami-
Genomic Signatures of Inﬂ  uenza A 
Pandemic (H1N1) 2009 Virus
Guang-Wu Chen and Shin-Ru Shih
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 12, December 2009  1897 
Author afﬁ   liation: Chang Gung University, Taoyuan, Taiwan, Re-
public of China
DOI: 10.3201/eid1512.090845RESEARCH
no acid signatures is unclear, because the new viral genes 
evolved after they were introduced into the swine popula-
tion some years ago.
By adopting the entropy proﬁ  ling approach, this study 
attempts to update inﬂ  uenza A viral signatures on the ba-
sis of all inﬂ  uenza sequences from the National Center for 
Biotechnology Information (NCBI). In addition to provid-
ing an updated list of human-avian signatures, this study 
also computes the human-swine signatures and analyzes 
the amino acid sequences of pandemic (H1N1) 2009 virus 
at the host species–speciﬁ  c positions to elucidate the adap-
tive mutation of inﬂ  uenza A viruses in these host species. 
As more new inﬂ  uenza virus isolates are collected and their 
sequences analyzed, the signatures at the host species–
speciﬁ  c positions serve as predictors of adaptive mutation, 
subsequently providing valuable information to help in pre-
paring for potential pandemics.
Materials and Methods
Inﬂ  uenza Virus Sequences
All inﬂ  uenza A virus protein sequences from the NCBI, 
as of May 28, 2009, were downloaded and analyzed. These 
full-length or partial sequences were grouped according to 
the hosts from which the viruses were isolated: humans, 
avian, and swine. In particular, to observe how these virus-
es vary in terms of residues, the newly deposited pandemic 
(H1N1) 2009 virus sequences were considered separately 
from the human isolates. For each host-speciﬁ  c group, se-
quences belonging to each viral protein were aligned using 
the program ClustalW (5). Based on the proposed signature 
identiﬁ  cation procedure, 2 surface proteins, HA and NA, 
were not analyzed because their extensive genetic diversity 
prevents satisfactory multiple alignment within either hu-
man or avian viruses. As an alternatively translated protein 
product from the PB1 gene, PB1-F2 is also not included in 
the analysis because it terminates prematurely at position 
12. For each of the 4 groups of data, i.e., human, avian, 
swine, and pandemic (H1N1) 2009, eight alignments were 
analyzed: PB2, PB1, PA, NP, M1, M2, NS1, and NS2. The 
total number of sequences varied from gene to gene and 
from host to host, subject to their availability at the NCBI. 
For human-isolated viruses (excluding strains of pandemic 
(H1N1) 2009 virus), >3,000 sequences of the 8 proteins 
were analyzed. For avian-isolated, swine-isolated, and 
pandemic (H1N1) 2009 viruses, the numbers of sequences 
were ≈3,500, 350, and 70, respectively.
Recent Ancestors of Pandemic (H1N1) 2009 Viruses
Smith et al. (6) performed evolutionary analysis of the 
early development of the pandemic, indicating that spo-
radic infection of humans with triple reassortant and other 
subsequent reassortant swine viruses occurred before the 
2009 human outbreak. To elucidate the transition of amino 
acid residues along this evolutionary course, we collected 
and analyzed the protein sequences of 18 recent ancestral 
swine viruses of the new H1N1 viruses (hereinafter termed 
“recent ancestral swine viruses”) for 1999–2009 from 
the ancestral lineages of the new pandemic (H1N1) 2009 
strains. The sampling was based on the phylogenetic trees 
published in a study by Smith et al. (6). Although a number 
of swine virus origins have been reported, resulting in vari-
ous genetic lineages and subtypes, we are most interested in 
identifying a swine virus population from which the current 
pandemic (H1N1) 2009 virus might have evolved directly. 
Not only are those 18 strains chronologically closer (after 
the years 1997–1998) to the pandemic (H1N1) 2009 viruses 
but their PB2 and PA genes are also descendants of avian 
viruses, which complies with the conclusion drawn from 
recent publications. The online Appendix Table, available 
from http://www.cdc.gov/EID/content/15/12/1897-appT.
htm, summarizes the strain names and accession numbers 
of recent ancestral swine viruses included in this study.
Entropy-based Signature Identiﬁ  cation
For each amino acid position of the aligned sequences 
of the same virus type, i.e., avian, human, swine, or pan-
demic (H1N1) 2009, an entropy value was computed by 
using the formula –ΣPi × ln(Pi), as described by Chen et al. 
(4). This formula follows the deﬁ  nition of Shannon entropy 
(7) that has been used to evaluate the diversity of a system. 
In this study, an entropy was used to measure the variabil-
ity of aligned amino acid residues at a given genomic posi-
tion, where i = 1 to 20 represents 20 different amino acid 
residues, and Pi represents the probability density of the 
respective residue. An entropy value ranges from 0 (only 1 
residue present at that position) to 2.996 (all 20 residues are 
equally represented). As is assumed, a position at which the 
entropy is less than or equal to a prespeciﬁ  ed threshold has 
a consensus residue for that virus type. When viruses iso-
lated from 2 host species are compared, a species-speciﬁ  c 
signature position is considered to have different consensus 
amino acid residue from each of the 2 viruses at the same 
position. In this study, an entropy threshold of 0.33 was 
used, based on the PB2-627 position of 3,391 avian inﬂ  u-
enza sequences.
Results
In 2006, we reported 52 avian-human signatures based 
on a small set of inﬂ  uenza sequence data of 15,785 protein 
sequences. The selection was based on an entropy thresh-
old value of 0.4 set at position 627 in the PB2 gene (82 Es 
and 13 Ks from 95 avian PB2 sequences) because that po-
sition has been considered associated with host-restriction 
(8–11). Of the 52 positions, 45 are in the genes PB2, PB1, 
PA, NP, M1, M2, NS1, and NS2 examined in this work. 
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Today, >100,000 inﬂ  uenza protein sequences are available 
at NCBI, and a new entropy threshold of 0.33 was set based 
on the currently available avian sequences of PB2-627, 
which contain 3,113 Es, 228 Ks, 46 Vs, 2 As, and 2 Gs. 
This threshold was adopted to update the list of 47 avian-
human signatures in Table 1 for the 8 proteins of interest. 
Consistent with our earlier ﬁ  ndings, most signatures are 
located on the NP gene (15 positions), followed in number 
by PA (10 positions), PB2 (9 positions), M2 (5 positions), 
M1 (3 positions), PB1 (2 positions), NS2 (2 positions), and 
NS1 (1 position). The 20 signatures associated with PB1, 
NP, and M1 do not differ between the 2 datasets of 2006 
and 2009. In PB2, two new signatures are identiﬁ  ed at posi-
tions 567 and 702. These 2 positions were only just omitted 
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Table 1. Amino acid residues of pandemic (H1N1) 2009 virus strains at 47 positions where avian–human signatures are located* 
Gene Position Avian virus residue  Human virus residue 
Pandemic (H1N1) 
2009 virus residue 
PB2 44 A(2,838), S(39), T(1) S(2,734), A(30), L(2) A(61) 
199 A(2,816), S(22), D(4), T(2), V(1) S(2,781), A(8) A(61) 
271 T(2,758), I(47), A(21), M(5), Q(1) A(2,770), T(15), S(1) A(61) 
475 L(3,355), M(25), I(1) M(2,747), L(8), I(1) L(61) 
567 D(3,116), E(257), N(18), V(3), G(3), A(2), K(1) N(2,736), D(18), S(1) D(61)
588 A(3,175), T(91), I(72), V(43), S(3), P(1), D(1) I(2,734), A(8), V(6),T(4), L(1), S(1) T(61) 
613 V(3,343), A(29), I(19) T(2,651), I(71), A(23), V(9), S(1) V(61)
627 E(3,113), K(228), V(46), A(2), G(2) K(2,746), E(6), R(3) E(61)
702 K(3,232), R(131), Q(1) R(2,731), K(22), G(1), I(1) K(61)
PB1 327 R(3,340), K(54), G(1) K(2,489), R(275) R(80)
336 V(3,350), I(26), A(16) I(2,595), V(168), T(1) I(80)
PA 28 P(2,915), S(7), L(5), T(1) L(2,736), P(19), R(2), S(2), Q(1) P(61)
55 D(2,906), N(29) N(2,752), D(13) D(61)
57 R(2,849), Q(77), K(4), W(3), L(2) Q(2,736), R(20), L(6), K(3) R(61)
100 V(2,759), A(109), I(68), F(1) A(2,727), V(27), T(7), I(2), S(1) V(61)
225 S (2,854), N(7), C(6), G(1) C(2,736), S(29), G(1) S(61)
268 L(3,317), F(14), I(2), V(1) I(2,724), L(35), V(2) L(61) 
356 K(3,309), R(34), N(7), E(1), I (1) R(2,705), K(30) R(61)
404 A(3,098), S(220), T(10), P(4), R(1), V(1) S(2,706), A(28), P(1) A(61) 
409 S(3,100), N(191), G(4), I(1), R(1), K(1) N(2,723), S(11), I(1) N(61)
552 T(3,304), A(1), N(1) S(2,721), T(10), N(2), R(1), I(1) T(61) 
NP 16 G(3,379), S(58), D(8), C(1) D(2,884), G(16) G(120), D(1)
33 V(3,173), I(284), A(1), D(1) I(2,876), V(25) I(121)
61 I(3,419), M(30), V(19), L(6) L(2,881), I(19) I(121)
100 R(3,422), K(34), V(23), S(1) V(2,842), I(52), R(4), A(3), L(1), M(1) V(68), I(46)
109 I(3,407), V(48), T(22), M(2), S(1) V(2,820), I(77), A(3), T(3) I(114)
214 R(3,282), K(52), T(3), L(1) K(2,897), R(25) R(114)
283 L(3,309), F(4), P(3), I(3) P(3,062), L(19), S(3) L(114)
293 R(3,275), K(40) K(3,020), R(65) R(114)
305 R(3,238), K(32), S(2) K(3,052), R(33) K(114)
313 F(3,191), L(43), S(10), Y(1), C(1), I(1) Y(3,064), F(21) V(114)
357 Q(2,766), K(33), T(3), R(2) K(3,052), R(46), Q(5) K(114)
372 E(2,742), D(69), G(3), K(2) D(3,051),E(51), N(1) E(114)
422 R(2,818), K(2) K(2,891), R(51) R(114)
442 T(2,793), S(12), A(5) A(2,890), T(51), R(1) T(114)
455 D(2,792), N(3), E(1) E(2,890), D(51), T(1) D(114)
M1 115 V(3,794), I(15), G(2), L(2), M(1) I(3,586), V(19) V(151)
121 T(3,684), A(126), P(4) A(3,599), T(7) T(151) 
137 T(3,806), D(12), A(8), P(1), S(1) A(3,577), T(25) T(146) 
M2 11 T(2,890), I(190), S(8), E(1) I(3,805),T(102) T(55)
20 S(3,032),N(76), K(12), R(3), I(2) N(3,859), S(49) S(55)
57 Y(3,040), H(5), N(1), C(1) H(3,804),Y(65), D(25), Q(5), R(5), N(4) Y(55)
86 V(2,894), A(6), I(4), D(1), L(1), F(1), S(1) A(3,781), V(26), T(10), D(1) V(55)
93 N(2,710), T(13), D(3), H(3), S(3), Y(2), I(1) S(3,699), N(69), Q(2), R(1), H(1), I(1) N(55)
NS1 81 I(2,652), V(43), T(8), M(2), S(1), Y(1), G(1) M(2,860), I(59), V(4) I(93)
227 E(3,080), G(60), K(31), S(1) R(2,863), G(8), K(2), W(1), E(1) Delete
NS2 107 L(3,147), P(2), S(2), F(1), Q(1)  F(2,850), L(45), S(1), V(1)  L(93) 
*Boldface indicates dominant amino acid residue type. PB, polymerase B; PA, polymerase A; NP, nucleoprotein; M, matrix; NS nonstructural.RESEARCH
from the 2006 list because their entropy values (0.490 and 
0.404, respectively) exceeded the 0.4 threshold, based on 
the 95 avian sequences examined at that time. New entries 
in Table 1 also include PA-100, M2-93, and NS1-81. In 
2006, although PB2-674 was reported as a signature, it is 
disqualiﬁ  ed here because the entropy of 0.3376 (3,146 As, 
88 Es, 87 Ts, 38 Ss, 13 Gs, 4 Vs, and 1 K for avian virus) 
exceeds the new 0.33 threshold at this position. Similarly, 
PA-382 (2,421 Ds, 311 Es, 2 Vs, and 1 N in human viruses, 
with an entropy of 0.3633) and NS2-70 (2,898 Ss, 352 Gs, 
28 Rs, and 1 D in avian viruses, with an entropy of 0.3483) 
were both removed from the 2006 list.
Taubenberger et al. (12) identiﬁ  ed 10 polymerase gene 
positions that separate avian viruses from human inﬂ  uenza 
A viruses. Table 1 shows 8 of them (PB2 199, 475, 567, 
627, and 702; PA 55, 100, and 552), suggesting that the 
method is robust in ﬁ  nding these signatures. Two other 
polymerase gene positions that Taubenberger et al. also 
reported are PB1-375 and PA-382; the latter has already 
been mentioned above. The other missing position in Table 
1, PB1-375, has an entropy value of 0.8865 for human and 
0.6338 for avian viruses. This position was also excluded 
from the 2006 list because of an entropy of 0.698 from avi-
an viruses, which substantially exceeded the 0.4 threshold.
To elucidate the potential adaptive mutations of the 
pandemic (H1N1) 2009 viruses, we studied the amino acid 
sequences of pandemic (H1N1) 2009 viruses at the posi-
tions that represent the so-called species-speciﬁ  c signatures 
of avian and human viruses.  As shown in to the last column 
of Table 1, 36 of the 47 positions display avian-like signa-
tures in the pandemic (H1N1) 2009 virus. Two positions, 
PB2-588 and NP-313, exhibit neither avian- nor human-
like signatures. Eight human-like signatures were found 
in pandemic (H1N1) 2009 strains, except for NS1-227, in 
which all new viruses have an early-terminating NS1 pro-
tein and, therefore, contain no residue.
Table 1 presents the updated avian-human signatures 
for inﬂ  uenza A viruses; Table 2 summarizes the swine-
human signatures. Medical literature documents that the 
swine virus population has distinct evolutionary lineages 
that originated from the classic 1918 virus referred to as 
classic or North American swine virus, and the others of 
post-1979 Eurasian swine virus and subsequent triple reas-
sortants. Because the residue diversity at many positions 
markedly increased for these swine viruses because of 
their distinct origins, only 8 swine-human signatures met 
the 0.33 threshold. Unlike some positions in which human-
like signatures of pandemic (H1N1) 2009 were found 
(Table 1), in this study, all 8 locations of the swine-human 
signature of this new virus are characteristic of swine. No-
tably, Table 1 lists all 8 positions in Table 2, with each hav-
ing the same signature as in the avian virus. Restated, avian 
and swine viruses contain the same amino acid residue at 
the 8 human-swine signature positions.
We attempted to further elucidate the transition of the 
amino acid residue on the pandemic (H1N1) 2009 virus 
that have human signatures by sampling 18 recent ancestral 
swine viruses (online Appendix Table). Doing so enables 
us to examine more closely the prevalence of amino acid 
residues speciﬁ  cally with pandemic (H1N1) 2009 viruses. 
Table 3 summarizes the amino acid statistics of these re-
cent ancestral swine viruses together with avian, human, 
and pandemic (H1N1) 2009 sequences at the 8 positions 
containing human residues for pandemic (H1N1) 2009 vi-
rus in Table 1. Consider PB2-271, for example, avian vi-
ruses have signature T, whereas human viruses have signa-
ture A. Although pandemic (H1N1) 2009 viruses also have 
the human signature A, their predecessors, i.e., the recent 
ancestral swine viruses, have already acquired the human 
signature A at this position. PB1-336, along with PA-409, 
NP-33, -100, -305, and -357, follows the same residue tran-
sition, all showing human-characteristic residues in both 
recent ancestral swine and pandemic (H1N1) 2009 viruses. 
PA-356 is the only exception, where the residue in recent 
ancestral swine viruses still maintains an avian-character-
istic K before changing to a human residue R in pandemic 
(H1N1) 2009 viruses. Of particular interest is whether the 
transition from K to R at position PA-356 is responsible for 
the ability of pandemic (H1N1) 2009 viruses to replicate 
and transmit efﬁ  ciently in humans.
After all 8 human residue-containing positions of pan-
demic (H1N1) 2009 viruses were found to be within PB2, 
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Table 2. Amino acid residues of pandemic (H1N1) 2009 virus strains at 8 positions where swine–human signatures are located* 
Gene Position Swine virus residue (all subtypes)  Human virus residue 
Pandemic (H1N1) 2009 
virus residue 
PB2 44 A(301), S(27), C(1)  S(2,734), A(30), L(2) A(61)
PA 268 L(325), I(31), T(1)  I(2,724), L(35), V(2) L(61)
552 T(280), S(25) S(2,721), T(10), N(2), I(1), R(1) T(61)
M1 137 T(429), A(39) A(3,577), T(25) T(146)
M2 57 Y(343), H(23), R(2) H(3,804),Y(65), D(25), Q(5), R(5), N(4) Y(55)
86 V(324), A(24), S(1) A(3,781), V(26), T(10), D(1) V(55)
93 N(320), S(23) S(3,699), N(69), Q(2), R(1), H(1), I(1) N(55)
NS2 107 L(299), F(25)  F(2,850), L(45), S(1), V(1)  L(93)
*Boldface indicates dominant amino acid residue type. PB, polymerase B; PA, polymerase A; M, matrix; NS, nonstructural.  Genomic Signatures of Pandemic (H1N1) 2009 Virus
PB1, PA, and NP protein genes, all amino acid positions 
of these 4 proteins were scanned for their residue transi-
tions among the 4 virus populations shown in Table 3. The 
change in the amino acid that may be associated with the 
transformation of pandemic (H1N1) 2009 virus is sum-
marized in Table 4. As well as PA-356, already shown in 
Table 2, two additional positions, PB2-684 and PA-204, 
showed the same dominant amino acid residue in avian 
and recent ancestral swine viruses, but a different domi-
nant residue in pandemic (H1N1) 2009 viruses and human 
viruses. Dominance is deﬁ  ned here as 1 residue containing 
the largest sequence count compared with other residues at 
a particular aligned position. The previously used entropy 
measurement in Tables 1, 2, and 3 does not apply to the 
positions listed in Table 4, in which we emphasize the ami-
no acid transition of dominant residues instead of highly 
conserved ones subject to the prescribed entropy threshold 
0.33. Other than those 3 positions, PB1-216 was found to 
contain a human residue G in 8 of 9 recent ancestral swine 
viruses that are closer to pandemic (H1N1) 2009 viruses 
in the phylogenetic tree published in a study by Smith et 
al. (6). However, for the other 7 recent ancestors that are 
more distant from pandemic (H1N1) 2009 viruses, PB1-
216 maintains an avian-residue S in 6 of 7 viruses. Our 
results show that the position-speciﬁ  c transition may serve 
as a molecular marker for monitoring such adaptive muta-
tions in the future.
Discussion
Although most studies confer that the death rate as-
sociated with pandemic (H1N1) 2009 infection is more 
moderate than that of subtype H5N1 infection, its virulence 
may vary with adaptive mutations in viral genes, subse-
quently increasing the likelihood that the new virus alters 
its virulence in the new host species. Many of the previous-
ly identiﬁ  ed virulence factors are apparently not involved. 
For instance, no E to K mutation at position 627 of PB2 is 
observed, which has been considered an important factor 
for avian virus to efﬁ  ciently replicate in mammalian sys-
tems (8–11). Previous studies have indicated that PB1-F2 
contributes viral pathogenesis in the mammalian system 
(13,14). No PB1-F2, however, is predicted in pandemic 
(H1N1) 2009 viruses because it terminates prematurely at 
position 12. Its NS1 protein is truncated at position 220 and, 
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Table 3. Position-specific residue transitioning for influenza A virus among avian, recent ancestral swine, pandemic (H1N1) 2009, and 
human strains, for those 8 positions of pandemic (H1N1) 2009 virus showing human-characteristic signatures* 
Gene Position Avian virus residue 
Recent swine 
viruses residue† 
Pandemic (H1N1) 
2009 virus residue  Human virus residue 
PB2 271 T(2,758), I(47), A(21), M(5), Q(1)  A(17), S(1) A(61)  A(2,770), T(15), S(1) 
PB1 336 V(3,350), I(26), A(16)  I(16) I(80) I(2,595), V(168), T(1) 
PA 356 K(3,309), R(34), N(7), E(1), I(1)  K(16), R(1) R(61) R(2,705), K(30) 
409 S(3,100), N(191), G(4), I(1), R(1), K(1) N(17) N(61) N(2,723), S(11),I (1)
NP 33 V(3,173), I(284), A(1), D(1) I(18) I(121) I(2,876), V(25)
100 R(3,422), K(34), V(23), S(1) V(17), I(1)  V(68), I(46) V(2,842), I(52), R(4), A(3), L(1), 
M(1)
305 R(3,238), K(32), S(2) K(18) K(114) K(3,052), R(33)
357 Q(2,766), K(33), T(3), R(2) K(17), R(1)  K(114) K(3,052), R(46), Q(5)
*Boldface indicates dominant amino acid residue type. PB, polymerase B; PA, polymerase A; NP, nucleoprotein. 
†Eighteen recent ancestral swine viruses as listed in the online Appendix Table (available from www.cdc.gov/EID/content/15/12/1897-appT.htm). We 
consider recent ancestral strains phylogenetically neighboring to the pandemic 2009 strains, in particular for PB2 and PA genes they are clustered 
together with recent avian strains because the pandemic (H1N1) viruses were reported to originate from avian viruses around 1998. Note that for 1 strain, 
A/swine/Missouri/4296424/06(H2N3), the PA sequence was not found anywhere near the other 17 recent swine strains of interest. Two PB1 sequences, 
A/swine/Hong Kong/78/2003(H1N2) and A/swine/Korea/C13/2008(H5N2), were also found distantly located from the other 16 recent swine PB1 
sequences. We excluded these 3 sequences from the amino acid statistics in this table because of their genetic deviation from the remaining ancestral 
swine viruses we have collected here.
Table 4. Amino acid positions containing the same residue in avian and recent ancestral swine viruses, yet changed to a  
different one in pandemic (H1N1) 2009 and human viruses* 
Gene Position Avian virus residue 
Recent swine 
viruses residue† 
Pandemic (H1N1) 
2009 virus residue  Human virus residue 
PB2 684 A(3,278), T(70), S(11), V(9), G(6), 
D(1), E(1)
A(18) S(61) S(1,944), A(806), G(2), P(2), 
Y(1)
PB1 216 S(3,299), G(62), N(37), C(11), I(7)  G(9), S(7)‡  G(80)  G(1,708), S(1,039), N(5), I(4), 
D(1)
PA 204 R(2,202), K(674), E(1), G(1), S(1)  R(17) K(61) K(1,776), R(991) 
356 K(3,309), R(34), N(7), E(1), I(1)  K(16), R(1)  R(61) R(2,705), K(30) 
*Boldface indicates dominant amino acid residue type. PB, polymerase B; PA, polymerase A. 
†Same 18 recent ancestral swine viruses used in Table 3.  
‡PB1-216 is dominated by residue G (G[8), S[1]) when considering only a subset of 9 PB1 sequences that are phylogenetically closer to pandemic 
(H1N1) 2009 virus. This statistic clearly shows the amino acid residue transition from avian to human signature within the population of recent swine 
viruses. RESEARCH
therefore, lacks a PDZ ligand interacting domain. As sug-
gested recently, the presence of this PDZ ligand domain in-
creases the pathogenicity of avian inﬂ  uenza A viruses (15). 
Regardless of whether these known factors are missed, a 
previous study has demonstrated that the virulence of pan-
demic (H1N1) 2009 virus is higher than that of seasonal 
inﬂ  uenza A viruses (16). Although a virulence marker and 
a host range factor may not be necessarily linked tightly, 
recent investigations have also demonstrated that altering 
PB2-627 from E to K in the avian viruses increases its viru-
lence in the mammalian experimental system (9–11). For 
example, avian inﬂ  uenza virus subtype H7N7 reportedly 
infects humans (17). A human isolate from a fatal case had 
its PB2-627 changed from avian-characteristic E to K. Cor-
respondingly, the species-associated signatures identiﬁ  ed 
in this study may serve as potential molecular targets for 
further evaluating how they impact the virulence of pan-
demic (H1N1) 2009 viruses in humans.
As shown in Tables 1 and 2, the number of signature 
positions decreases signiﬁ  cantly from 47 (human vs. avian) 
to 8 (human vs. swine), and the positions of the latter are 
a subset of those of the former. These observations may 
have the following implications. First, the 3 host species of 
interest differ, with each providing a unique environment 
for infection by the inﬂ  uenza virus. When the avian virus 
enters humans or swine, its genetic feature is shaped by a 
particular evolutionary path. The viruses, therefore, have 
different signatures. Second, some avian-like signatures 
are preserved in swine viruses, suggesting that both avian 
species and swine may provide similar conditions for har-
boring inﬂ  uenza A viruses. The body temperature may be 
a determinant. As is generally known, many avian species 
have a body temperature exceeding 40oC; for most pigs it is 
variable but still higher than the human body temperature, 
which is 37oC. Consequently, the signatures are retained 
when an avian virus enters the swine population, with simi-
lar signature-related viral replication mechanisms in both 
species. Third, the 39 signature positions shown in Table 
1, but absent from Table 2, may be correlated with certain 
functional domains that interact with host factors unique in 
humans while differing signiﬁ  cantly from those of avian 
and swine. Finally, the number of signature positions of 
swine versus humans is substantially lower than those of 
avian versus humans, suggesting that the species barrier to 
humans is easier for a swine virus to cross than for an avian 
virus.
The entropy-based computation depends strongly on a 
good multiple sequence alignment. The 2 surface proteins 
HA and NA are excluded from this analysis because both 
contain sequences that diverged sufﬁ  ciently from so many 
subtypes of a given species. Locating conserved residues at 
particular positions on the basis of these alignments is ex-
tremely difﬁ  cult. The entropy threshold is the other param-
eter requiring attention to locate a signature position. In this 
study, the entropy determined from PB2-627 of the aligned 
residues of all avian viruses is used because PB2-627 is the 
most laboratory-proved host-restriction marker (8–11). A 
complete new set of signatures can be reproduced rapidly 
by using a different entropy threshold based on other fac-
tors. The diverse genetic origins of inﬂ  uenza viruses would 
also have great impact on the reported signatures. The 
proposed entropy-based method to reach the 8 positions 
listed in Table 2 was based on all swine viruses of differ-
ent origins, including North American-(classic 1918) ori-
gin strains, Eurasian (post-1979 avian)-origin strains, and 
recent triple reassortants. A comparison of, for example, 
all human viruses versus classic 1918-origin swine viruses 
before 1978 (≈75 strains, or 20% of our swine sequence 
population) would report 60 signature positions (data not 
shown). In this work, we included all swine viruses of mul-
tiple origins in producing Table 2 to consider only host-spe-
ciﬁ  c genomic signatures that have been shaped by the same 
swine species regardless of origin. For the same reason, we 
did not subdivide avian or human populations into lineages 
when reporting avian-human signatures in Table 1.
This study analyzed a complete collection of species-
speciﬁ  c inﬂ  uenza A viral sequences, including the long-
evolving avian, recent ancestral swine and human viruses, 
as well as pandemic (H1N1) 2009 viruses, which is still 
in its infancy. The amino acid sequence transition of pan-
demic (H1N1) 2009 virus at the signature positions was 
also elucidated by applying the entropy-based signature 
analysis to these sequences. They were found mostly to 
be characteristic of avian species, as presented in Table 1. 
Notably, 8 of them changed from avian-like signatures to 
human-like signatures. Close examination of the residue 
transition at these 8 positions in Table 3 showed that PA-
356, unlike the other 7 positions, retained an avian-like sig-
nature in the recent ancestral swine population and changed 
to a human-like signature only in pandemic (H1N1) 2009. 
This ﬁ  nding suggests that PA-356 may be related to host-
restriction factors from swine to human species. Similarly, 
all ribonucleoprotein positions were scanned for the same 
transitioning pattern as in PA-356, i.e., a retained avian-
like residue in the recent ancestral swine population and 
a change to the human residue in pandemic (H1N1) 2009 
viruses. Table 4 lists them all. Although 1 of the positions, 
PB1- 216, was not dominated by the residue S as we would 
have expected, it exhibited a mixture of 2 residues involv-
ing a transition from avian to human viruses. In summary, 
Table 4 provides a list of candidate host-restriction factors 
that we believe are important to adaptive mutation of inﬂ  u-
enza A viruses among the 3 host species. Continuous moni-
toring of these signatures in nonhuman species will help in 
inﬂ  uenza surveillance and in evaluating the likelihood of 
further adaptation to humans.
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